Schwann cell dysfunction contributes to diabetic wound pathology which is partially ameliorated by oncostatin M treatment
Shahreen Mahbub Rahman, Griffen WakeliniD, Laura V. Young, Jim Parker, Leah Saleh, James Fawcett, Adam Patrick William Johnston
Abstract
Chronic diabetic wounds represent a major clinical burden and are strongly associated with peripheral neuropathy, yet the contribution of nerve-associated Schwann cells to impaired healing remains poorly defined. Here, we investigated Schwann cell dynamics in cutaneous wound repair using the db/db model of type 2 diabetes. Full-thickness excisional wounds in db/db mice exhibited delayed closure, reduced dermal and epidermal thickness, and diminished cellular proliferation compared to non-diabetic controls. Diabetic wounds also demonstrated impaired re-innervation and a marked reduction in both total (S100{beta}+) and dedifferentiated (p75NTR+) Schwann cells, including decreased Schwann cell proliferation. These findings indicate that diabetes disrupts the injury-induced Schwann cell response that is essential for normal repair. Transcriptomic analyses revealed that injury-activated Schwann cells upregulate multiple trophic factors, including oncostatin M (OSM), while single-cell RNA sequencing demonstrated broad expression of OSM receptors (Osmr and Il6st) across wound-resident keratinocytes, fibroblasts, and vascular-associated cells, suggesting widespread responsiveness to OSM signalling during repair. Therapeutic administration of OSM to diabetic wounds significantly accelerated closure, reduced wound width and area, and increased dermal and epidermal thickness. Mechanistically, OSM enhanced epidermal proliferation, angiogenesis, and cutaneous axon regeneration. Collectively, these data identify Schwann cell dysfunction as a contributor to impaired diabetic wound healing and demonstrate that augmenting a Schwann cell-derived paracrine signal can partially rescue key reparative processes. Our findings support a regulatory role for Schwann cells in coordinating epithelial, vascular, and neural repair responses and highlight OSM signalling as a potential therapeutic strategy for chronic diabetic wounds.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A regenerative stem cell-derived matrix accelerates functional dermal wound repair in a diabetic model
Colette A. Abbey, Joshua Benton, … Carl A. Gregory·bioRxiv·Feb 23, 2026
- Multi-omics analysis of type II diabetic wound healing reveals CD44-mediated immune cell crosstalk dysfunction in mice and humans
Mateusz S. Wietecha, Jingbo Pang, … Timothy Jon Koh·bioRxiv·Apr 29, 2026
- Cholinergic modulation engages a CHRM1-IL-17 neuroimmune axis to promote diabetic wound repair
Zhuqing Li, Georgios Theocharidis, … Aristidis Veves·bioRxiv·Nov 9, 2026
- Transcriptional heterogeneity in diabetic foot wounds
T. Sandoval-Schaefer, Q. Phan, … V. Horsley·bioRxiv·Feb 16, 2023
- Adenosine diphosphate contributes to wound healing in diabetic mice through P2Y1 and P2Y12 receptors activation
P. A. Borges, I. Waclawiak, … C. F. Benjamim·bioRxiv·Oct 22, 2020
- A Diabetic Mice Model For Studying Skin Wound Healing
C. Poblete Jara, G. Nogueira, … E. P. de Araujo·bioRxiv·May 28, 2022